Mutual of America Capital Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.34M | Sell |
55,605
-2,730
| -5% | -$280K | 0.05% | 414 |
|
|
2026
Q1 | $6.37M | Sell |
58,335
-141
| -0.2% | -$13.4K | 0.07% | 322 |
|
|
2025
Q4 | $4.74M | Buy |
58,476
+10,028
| +21% | +$863K | 0.05% | 447 |
|
|
2025
Q3 | $4.24M | Buy |
48,448
+10,451
| +28% | +$933K | 0.04% | 506 |
|
|
2025
Q2 | $3.16M | Buy |
37,997
+2,666
| +8% | +$223K | 0.03% | 638 |
|
|
2025
Q1 | $2.96M | Buy |
35,331
+2,038
| +6% | +$190K | 0.03% | 662 |
|
|
2024
Q4 | $3.07M | Sell |
33,293
-3
| -0% | -$289 | 0.03% | 690 |
|
|
2024
Q3 | $3.09M | Sell |
33,296
-491
| -1% | -$42.5K | 0.03% | 711 |
|
|
2024
Q2 | $2.78M | Sell |
33,787
-1,449
| -4% | -$106K | 0.03% | 752 |
|
|
2024
Q1 | $2.34M | Sell |
35,236
-2,639
| -7% | -$163K | 0.03% | 838 |
|
|
2023
Q4 | $2.15M | Sell |
37,875
-1,568
| -4% | -$82.1K | 0.02% | 869 |
|
|
2023
Q3 | $2.15M | Sell |
39,443
-2,478
| -6% | -$147K | 0.03% | 839 |
|
|
2023
Q2 | $2.82M | Sell |
41,921
-3,089
| -7% | -$188K | 0.03% | 765 |
|
|
2023
Q1 | $2.32M | Sell |
45,010
-1,962
| -4% | -$95.3K | 0.03% | 848 |
|
|
2022
Q4 | $2.16M | Buy |
46,972
+43,127
| +1,122% | +$2.02M | 0.03% | 866 |
|
|
2022
Q3 | $195K | Buy |
3,845
+601
| +19% | +$30K | ﹤0.01% | 1371 |
|
|
2022
Q2 | $148K | Buy |
3,244
+475
| +17% | +$21.2K | ﹤0.01% | 1411 |
|
|
2022
Q1 | $129K | Buy |
2,769
+144
| +5% | +$6.44K | ﹤0.01% | 1460 |
|
|
2021
Q4 | $132K | Buy |
2,625
+66
| +3% | +$3.41K | ﹤0.01% | 1462 |
|
|
2021
Q3 | $136K | Buy |
2,559
+127
| +5% | +$7.15K | ﹤0.01% | 1452 |
|
|
2021
Q2 | $148K | Buy |
2,432
+177
| +8% | +$9.4K | ﹤0.01% | 1471 |
|
|
2021
Q1 | $110K | Buy |
2,255
+144
| +7% | +$6.75K | ﹤0.01% | 1524 |
|
|
2020
Q4 | $85K | Buy |
2,111
+83
| +4% | +$2.97K | ﹤0.01% | 1520 |
|
|
2020
Q3 | $66K | Buy |
2,028
+1,218
| +150% | +$36.6K | ﹤0.01% | 1492 |
|
|
2020
Q2 | $21K | Buy |
810
+91
| +13% | +$2.38K | ﹤0.01% | 1547 |
|
|
2020
Q1 | $18K | Buy |
719
+140
| +24% | +$4.32K | ﹤0.01% | 1511 |
|
|
2019
Q4 | $21K | Sell |
579
-22
| -4% | -$759 | ﹤0.01% | 1554 |
|
|
2019
Q3 | $21K | Buy |
601
+28
| +5% | +$895 | ﹤0.01% | 1556 |
|
|
2019
Q2 | $16K | Buy |
573
+121
| +27% | +$3.36K | ﹤0.01% | 1596 |
|
|
2019
Q1 | $14K | Buy |
452
+61
| +16% | +$1.63K | ﹤0.01% | 1593 |
|
|
2018
Q4 | $9K | Buy |
391
+92
| +31% | +$2.51K | ﹤0.01% | 1627 |
|
|
2018
Q3 | $12K | Buy |
299
+243
| +434% | +$8.76K | ﹤0.01% | 1595 |
|
|
2018
Q2 | $2K | Buy |
+56
| New | +$1.99K | ﹤0.01% | 1607 |
|
Other funds holding LMAT
CCA
CAM
CCM
Mutual of America Capital Management's LMAT Position: Q2 2026 in Review
Mutual of America Capital Management reduced its LeMaitre Vascular (LMAT) stake by 4.7% in Q2 2026, selling an estimated $280K and leaving 55,605 shares worth $5.34M. The position accounts for 0.05% of the portfolio, ranked #414.
Mutual of America Capital Management first reported a position in LMAT in Q2 2018 and has held it in 33 quarters since. The position peaked at $6.37M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Mutual of America Capital Management held 55,605 shares of LeMaitre Vascular worth $5.34M as of Q2 2026.
- Mutual of America Capital Management sold 2,730 LeMaitre Vascular shares in Q2 2026, an estimated $280K.
- LeMaitre Vascular made up 0.05% of Mutual of America Capital Management's portfolio in Q2 2026, its #414 holding.
- Mutual of America Capital Management first reported a position in LeMaitre Vascular in Q2 2018 and has held it in 33 quarters since.
- Mutual of America Capital Management's LeMaitre Vascular position peaked at $6.37M in Q1 2026.
- 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.